PCR-based Biomarker for Cancer Screening and Diagnosis
Current screening methodologies used to detect CRC are blood in stool tests (FOBT), colonoscopy, and sigmoidoscopy . For any of the three screening methods, effectiveness is limited however because of low compliance in patient preparation.
Decoding the Environmental Stress Response in Lung Diseases
Chronic Obstructive Pulmonary Disease (COPD) is an irreversible disease caused by environmental stress factors such as cigarette smoking, air pollution and respiratory infection. COPD is the 4th leading cause of mortality in the US (16M in US, 210 M people worldwide) and expected to be 3rd by 2020. Between 15-20% of smokers develop COPD. Only one gene is known to cause COPD (?1-antitrypsin) and contributes to less than 5% of COPD.
COPD is a dis
Chemotherapy - Modulated Vaccination for Breast Cancer: From Bench to Bedside
Approximately 40% of women diagnosed with breast cancer ultimately relapse. When relapse occurs, their disease is considered incurable. The challenge is to decrease the rate of relapse and develop better drug therapies for managing metastatic disease so that people can live longer. Dr. Emens is interested in developing a new approach to treating breast cancer by engaging the patients’ own immune system to seek out and destroy cancer cells. Em
Is Maryland a High Cancer Incidence State?
Results from the Maryland Cancer Registry
For years Maryland has ranked among the top states in cancer mortality. However,
as a result of programs such as the Maryland Cigarette Restitution Fund, which has provided education, prevention and screening for early detection, Maryland has seen a downward trend in cancer mortality. Maryland now ranks 19th among the states and DC, a change from 2nd two decades ago. It’s likely that the Maryland CRF has had a significant impact on this reducti
Pancreatic Cancer: Epidemiology in the Post-Genomic Era
Pancreatic cancer is the 4th leading cause of cancer deaths in the US in men and women, and represents about 2 percent of all cancer diagnoses world-wide. The average age on onset is 71 years of age. Many of the signs and symptoms of pancreatic cancers are not very specific to the disease itself. There are no reliable screening tests available for pancreatic cancer, which is why it is diagnosed late. Genes play an important role in the developmen
Hormones and Men’s Health: Findings from the Hormone Demonstration Program
The purpose of the Hormone Demonstration Program is to maximize the utility of the hormone data that is being generated from NHANES III to answer questions about men’s health, including prostate cancer and aging. We have patterned the Hormone Demonstration Program on the Prostate Cancer Demonstration Program. This Program is funded by the Maryland Cigarette Restitution Fund at Johns Hopkins. This is a highly collaborative process, with attendees
Human Papillomavirus and Oropharyngeal Squamous Cell Carcinoma
There are approximately 400,000 cases of head and neck cancer diagnosed world-wide each year. Head and neck cancer has a high mortality rate which has not improved in the past decade. Each year in the United Stated there are about 30,000 new head and neck cancer cases (~4,650 oropharyngeal cases) making it the sixth most common malignancy. HPV (Human Papillomavirus) is a small circular DNA virus only known to infect humans. The virus specifically
Does Economic Development Influence the Development of Cancer in Industrialized Nations?
We know that disparities in life expectancy, disability-adjusted life years, overall mortality and cancer mortality can develop as a result of regional variation, unique environmental, or differential socioeconomic circumstances. Factors such as economic development, diet, tobacco, alcohol consumption, health care expenditures and education levels, play a significant role in the incidence of cancer in industrialized nations and generally economic
Cancer Prevention & Control News and Announcements
LunchLearnLink, Wednesday, December 9, 2009 - 12 Noon to 1:30 pm
Speaker: Cynthia Sears, MD-- Topic: "Microbe-induced Colon Tumorigensis"
Location: Sheldon Hall --
Lunch will be served afterwards. If you can't join us in person, click on the link below to watch it live. RealPlayer is needed to view the seminar.
American Cancer Society Request for Applications (RFA):
The Role of Healthcare and Insurance in
Improving Outcomes in Cancer Prevention, Early Detection and Treatment
Application deadlines (electronic and paper): April 1st & October 15th, 2009
An email falsely attributed to Johns Hopkins describing properties of cancer cells and suggesting prevention strategies has begun circulating the Internet. For more information, click here.
The Cigarette Restitution Fund (CRF) at Johns Hopkins Research Grants Track Record
The CRF at Johns Hopkins has an eight-year track record. In all 131 research awards were made (research grants) totaling $19.7 million. In the Baltimore City public health grant, 3,646 men have been screened for prostate cancer, yielding 37 cancers found, diagnosed, and treated. See the attached chart (PDF) for detailed information.
Radiation Therapy Prolongs Life in Men with Recurrent Prostate Cancer
Men whose tumors recur after prostate cancer surgery are three times more likely to survive their disease long term if they undergo radiotherapy within two years of the recurrence.
Maryland has improved its standing among the states and the District of Columbia on cancer mortality -- going from 2nd in 1983-87 to 19th in all cancer sites 1999-2003. Five of the seven sites targeted by the Maryland Cigarette Restitution Fund are now out of the top ten ranks. Cancer incidence has just begun being tracked by virtually all states and D.C. and though Maryland's rates are higher than SEER, Maryland's ranks are generally higher for incidence than for mortality. See the attached chart (PDF) for detailed information.
Johns Hopkins Prostate Cancer Specialist William Nelson To Head Institution's Cancer Center
William G. Nelson, M.D., Ph.D., a member of The Johns Hopkins University School of Medicine faculty since 1992, has been selected to lead the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Most Adults Under 50 Unlikely Need Colorectal Screening
Young adults without a family history of bowel disease are unlikely to develop adenomas, the colorectal polyps most likely to lead to cancer, according to new research directed by scientists at the Johns Hopkins Kimmel Cancer Center. The finding supports current cancer screening guidelines recommending adults in general undergo screening colonoscopies starting at age 50.
GENOME UPDATE DEFINES LANDSCAPE OF BREAST AND COLON CANCERS
One year after completing the first large-scale report sequencing breast and colon cancer genes, Johns Hopkins Kimmel Cancer Center scientists have studied the vast majority of protein-coding genes which now suggest a landscape dominated by genes that each are mutated in relatively few cancers. Their report indicates that while little is known about these less-commonly mutated genes, they can be grouped into clusters according to their pathways.
NEW RADIOACTIVE AGENTS FOR COLON CANCER WORK INSIDE CELLS
Johns Hopkins scientists have developed a potentially novel way to fight colorectal cancer using tiny molecules to deliver potent barrages of radiation inside cancer cells, unlike current treatments that bind to the surface of cells and attack from the outside and cause unwanted side effects.
BROCCOLI SPROUT-DERIVED EXTRACT PROTECTS AGAINST ULTRAVIOLET RADIATION
A team of Johns Hopkins scientists reports in the Proceedings of the National Academy of Sciences that humans can be protected against the damaging effects of ultraviolet (UV) radiation -- the most abundant cancer-causing agent in our environment -- by topical application of an extract of broccoli sprouts.
The National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) would like to advise you of the availability of the -initial version of The Cancer Genome Atlas (TCGA) Data Portal.
The Data Portal serves as a storage and data management tool for TCGA data. All genomic characterization, sequencing and clinical data from TCGA are available within the Portal.
The Data Portal makes accessible the first of many sets of data from TCGA, and will be continually updated as data are generated. Please check back frequently for updates, additional data submissions, and improvements to the functionality of the database.
The Cancer Genome Atlas (TCGA) is a comprehensive and coordinated effort to accelerate our understanding of the molecular basis of cancer through the application of genome analysis technologies, including large-scale genome sequencing. This 3-year pilot project was announced in December of 2005, and after careful planning, the first funding awards were made in the Fall of 2006.
EXPERIMENTAL ANTI-CANCER DRUG MADE FROM CORN LILLIES KILLS BRAIN TUMOR STEM CELLS
A drug that shuts down a critical cell-signaling pathway in the most common and aggressive type of adult brain cancer successfully kills cancer stem cells thought to fuel tumor growth and help cancers evade drug and radiation therapy, a Johns Hopkins study shows.
American Cancer Society Funding for PH Faculty, Students (Multiple Due Dates)
The research program at the American Cancer Society focuses on beginning investigators, a program of targeted research and an enhanced commitment to psychosocial and behavioral, health services, health policy, epidemiological, clinical and cancer control research.
In response to identified needs in clinical oncology, the Society also sponsors grants in support of training for health professionals seeking to develop their clinical expertise and/or their ability to conduct independent research.
The Association for Schools of Public Health (ASPH) regularly provides information about grant opportunities. A full listing of grants notices can be found by visiting the Funding for Faculty section of the ASPH Web site.
Cancer Surveillance Information Resource for Marylanders
The Maryland Department of Health and Mental Hygiene has developed a new website to provide online information on Maryland-specific cancer information. The website offers easy access to the latest information on a wide-range of cancer surveillance issues.